Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 34,183 | 42,654 | 26,462 | 22,405 | 20,924 |
| Operating Income | -34,183 | -42,654 | -26,462 | -22,405 | -20,924 |
| Other Income | -196 | 47 | -90 | 190 | 161 |
| Pre-tax Income | -34,379 | -42,606 | -26,552 | -22,215 | -20,762 |
| Net Income Continuous | -34,379 | -42,606 | -26,552 | -22,215 | -20,762 |
| Net Income | $-34,379 | $-42,606 | $-26,552 | $-22,215 | $-20,762 |
| EPS Basic Total Ops | -1.82 | -2.44 | -1.56 | -1.34 | -1.31 |
| EPS Basic Continuous Ops | -1.83 | -2.44 | -1.56 | -1.34 | -1.31 |
| EPS Diluted Total Ops | -1.82 | -2.44 | -1.56 | -1.34 | -1.31 |
| EPS Diluted Continuous Ops | -1.83 | -2.44 | -1.56 | -1.34 | -1.31 |
| EBITDA(a) | $-34,183 | $-42,654 | $-26,461 | $-22,404 | $-20,923 |